Melissa Loucas

Till Lefranc is a partner in the London office of Gibson, Dunn & Crutcher. Mr. Lefranc is a member of the Private Equity, Mergers and Acquisitions and Capital Markets practice groups. Mr. Lefranc’s practice focuses on private equity, M&A and capital markets transactions across Europe. He advises clients on cross-border acquisitions and divestitures, growth capital investments, buy-outs, shareholder arrangements, minority investments, and management equity arrangements. He also a...

Brenda Coleman specialises in all aspects of corporate tax including private equity, fund formation, public and private M&A, restructurings, complex financings and tax disputes. Her experience includes acting for private equity funds, multi-asset managers, LPs, multinational companies, banks, hedge funds, Sovereign wealth funds and various UK Government departments. Brenda is described in Chambers UK 2022 as “extremely capable, very analytical and very thorough.” Clients say &...

Stephen A. Thierbach is a US-qualified corporate partner in the London office of Gibson, Dunn & Crutcher. A senior U.S. securities lawyer, he advises issuers, underwriters and selling shareholders on complex, innovative and multi-jurisdictional offerings of equity, equity-related and debt securities. He has a broad capital markets transactions practice, with a focus on initial public offerings and secondary offerings, and has represented corporates, investment banks, private equity firms ...

Carolyn Jackson helps clients solve complex cross-border issues involving the regulation of financial institutions and financial products, including derivatives. Carolyn's depth of knowledge and practical approach are shaped by her first-hand experience: she managed the New York trading desk of several investment banks and was formerly the executive director of the International Swaps and Derivatives Association, Inc. Trading firms, banks, asset managers, clearing houses and trading venues re...

Vincent Zabielski focuses on international nuclear energy matters, including providing strategic advice related to new-build EPC contracts, power purchase agreements, operation and maintenance, fuel supply chain, liability issues, and export controls. Prior to joining Pillsbury, Vincent was Senior Nuclear Counsel for the UAE nuclear new build program, where he was responsible for integration of nuclear licensing strategy with the largest-ever public financing of a public works project. During...

James Fisher is a partner in the Finance Group in Alston & Bird’s London office, focusing on debt capital markets, structured finance, securitisation, and derivatives transactions, with a particular specialty in advising corporate trust, agency, and issuer clients across a broad spectrum of cross-border and domestic financings.

Graham Defries is a top attorney recognized by Best Lawyers in the practice area(s) of Life Sciences Law. Graham, who practices law in London, United Kingdom, has been recognized since 2024. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Graham is held by other top lawyers in the same geographic and legal practice area.

Tim is a partner in Goodwin’s Technology and Life Sciences groups, based in the Cambridge and London offices.Mr. Worden regularly advises life sciences companies on licensing and partnering deals, R&D agreements, clinical trials agreements, distribution agreements, and a broad spectrum of regulatory matters. His expertise also includes advising on the IP and regulatory aspects of M&A transactions, IPOs and venture capital investments. Outside of the life sciences sector, Mr. Wor...

Arvin Abraham is a top attorney recognized by Best Lawyers in the practice area(s) of FinTech. Arvin, who practices law in London, United Kingdom, has been recognized since 2024. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Arvin is held by other top lawyers in the same geographic and legal practice area.

Sharon Lamb focuses her practice on transactional and regulatory advice in the health and life sciences sector. Sharon advises on global transactional mandates, including mergers and acquisitions and joint ventures in health services, pharma and life sciences, digital health and health data technologies. Sharon also provides strategic, regulatory and commercial support to UK and international clients on UK health and life sciences with a focus on health services, pharmaceuticals, medical devi...